pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
End looms for Cassava's simufilam in Alzheimer's disease
4 days ago · Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the end. The Austin, Texas-based biotech revealed that simufilam failed its ...
Deep Dive: Patients & Partnerships 2024 | pharmaphorum
Nov 8, 2024 · Delve into the critical issues surrounding patients, partnerships, and the US election in 2024. Explore the impact on drug development, pricing, and patient access in this in-depth analysis.
pharmaphorum - The Deep Dive Digital Magazine has fresh …
Feb 28, 2024 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, Research Partnership, PurpleLeaf Strategy, M3, and more
News | Timely industry updates for pharma and biotech leaders
4 days ago · pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
Pharma in the age of acceleration - pharmaphorum
That’s not to say that they have to rigidly adhere to the way pharma works, but there’s certainly a need for a highly collaborative approach and the generation of data that people will believe, albeit in a way that makes sense for the technology.
Six takeaways from JP Morgan 2024 - pharmaphorum
5 days ago · Discover the top six key takeaways from JP Morgan's 2024 conference, focusing on dealmaking trends in big tech, life science, AI, and advancements in cell and gene therapies, as well as the future ...
Building a strong pharma brand - pharmaphorum
This is when companies need to capture and listen to real-time feedback and this needs to go beyond simple sales numbers. To really understand how the product is being received, ‘softer’ touchpoints are needed, such as feedback from clinicians to sales representatives and medical science liaisons (MSLs), insights gathered from online patient forums and feedback from patient advocacy groups ...
Pills and polls: What the 2024 election means for pharma
President Biden’s passage of the Inflation Reduction Act, which, among many other provisions, allowed Medicare to negotiate drug prices for the first time and set a $35-per-month out-of-pocket ...
Views & Analysis | Perspectives on pharma industry issues
4 days ago · Diverse and engaging perspectives on pharma developments and debates from pharmaphorum editors, industry insiders, and contributing experts.